MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry
NCT: NCT07543874 · NOT_YET_RECRUITING
Brief Summary
The MITRAGEN5 Registry is an international, multicenter, observational registry that collects data on patients with mitral regurgitation who are treated with the fifth-generation MitraClip (G5) device. The MitraClip is a small device used to repair the mitral valve of the heart without open-heart surgery, a procedure called mitral valve transcatheter edge-to-edge repair (M-TEER). This registry aims to evaluate how safe and effective the MitraClip G5 is in everyday clinical practice across multiple hospitals worldwide. All procedures, tests, and follow-up visits are part of routine clinical care. No additional study-specific procedures are performed. Data are collected in anonymized form from participating centers.
Frequently Asked Questions
What is MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry?
MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry is a clinical trial registered under NCT07543874. Current status: NOT_YET_RECRUITING.
What is the status of NCT07543874?
The current status of NCT07543874 (MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry) is: NOT_YET_RECRUITING.
When did MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry start?
MITRAClip GENeration 5 Mitral Valve Transcatheter Edge-to-Edge Repair Registry started on 2026-05-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.